Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Compensated Liver Disease (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05663944
What this trial is testing

REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept Study

Who this might be right for
Advanced Chronic Liver Disease
Nottingham University Hospitals NHS Trust 41
Testing effectiveness (Phase 2)Study completedNCT01995071
What this trial is testing

Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)

Who this might be right for
Chronic Hepatitis CHepatitis C VirusCompensated Cirrhosis
AbbVie 89
Not applicableStudy completedNCT03778411
What this trial is testing

Non-invasive Evaluation of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease by Assessment of Spleen Stiffness Using VCTE by FibroScan.

Who this might be right for
Advanced Chronic Liver Disease, NASH
Indiana University 298
Not applicableStudy completedNCT03053180
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir (r) - Ombitasvir, + Dasabuvir Without Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis in the Russian Federation

Who this might be right for
Chronic Hepatitis C
AbbVie 60
Large-scale testing (Phase 3)Study completedNCT02219503
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis

Who this might be right for
Chronic Hepatitis C InfectionCompensated Cirrhosis
AbbVie 60
Large-scale testing (Phase 3)Looking for participantsNCT07704892
What this trial is testing

Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
GlaxoSmithKline 380
Large-scale testing (Phase 3)Study completedNCT03219216
What this trial is testing

Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 100
Post-approval studies (Phase 4)UnknownNCT01282398
What this trial is testing

Study About Simvastatin in Portal Hypertension in Compensated Cirrhosis

Who this might be right for
Portal Hypertension.Liver Cirrhosis
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 80
Testing effectiveness (Phase 2)Study completedNCT01640964
What this trial is testing

An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension

Who this might be right for
Compensated Cirrhosis and Portal Hypertension
Novartis Pharmaceuticals 47
Testing effectiveness (Phase 2)Study completedNCT06750276
What this trial is testing

Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.

Who this might be right for
Liver FibrosisHepatic Cirrhosis
AstraZeneca 40
Large-scale testing (Phase 3)UnknownNCT00437684
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 50
Large-scale testing (Phase 3)Study completedNCT02219490
What this trial is testing

Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection Genotype 1
AbbVie 1,596
Not applicableStudy completedNCT04546360
What this trial is testing

Spleen Stiffness Combined With Liver Stiffness Measured by 2D-SWE for the Screening of High-risk Varices in Compensated Advanced Chronic Liver Disease (CHESS2004)

Who this might be right for
Compensated Advanced Chronic Liver DiseaseVariceal Hemorrhage
Hepatopancreatobiliary Surgery Institute of Gansu Province 381
Early research (Phase 1)WithdrawnNCT00255359
What this trial is testing

Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers

Who this might be right for
Chronic Hepatitis C Virus Infection
Hadassah Medical Organization 60
Large-scale testing (Phase 3)Study completedNCT02247401
What this trial is testing

Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt

Who this might be right for
HCVHepatitis C InfectionGenotype 4
AbbVie 160
Testing effectiveness (Phase 2)Study completedNCT04210245
What this trial is testing

Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)

Who this might be right for
Compensated CirrhosisNonalcoholic Steatohepatitis
NGM Biopharmaceuticals, Inc 160
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Not applicableUnknownNCT04615091
What this trial is testing

Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic Surgery

Who this might be right for
Advanced Chronic Liver DiseaseSurgery--Complications
Azienda Ospedaliera Universitaria Integrata Verona 250
Not applicableNot Yet RecruitingNCT06749340
What this trial is testing

Examining the Effects of Different Resistive Exercise Programs in Individuals With Compensated Liver Cirrhosis

Who this might be right for
Coginitive DysfunctionCompensated Liver CirrhosisPhysical Dysfunction+1 more
Bahçeşehir University 20
Not applicableNot Yet RecruitingNCT07534046
What this trial is testing

Impact of Metabolic Disorders on cACLD Outcomes

Who this might be right for
Compensated Advanced Chronic Liver Disease
The Second Affiliated Hospital of Chongqing Medical University 4,307
Next Page